Milestone Scientific, Inc. MLSS
0.41
0.00
0.00%
as of 25 Sep
- Market cap
- $37.2M
- P/E
- 0.0×
Follow MLSS
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(136.47%) | (132.38%) | (135.39%) | (121.68%) | |
| (67.82%) | (65.01%) | (53.58%) | (50.54%) | ||
ROIC |
(204.19%) | (140.88%) | (148.05%) | (136.16%) | |
Return on Tangible Assets |
(215.43%) | (170.02%) | (181.72%) | (110.80%) | |
Average Days of Receivables |
29.29 | 28.72 | 23.70 | 40.80 | |
Free Cash Flow per Share |
(0.05) | (0.04) | (0.02) | (0.01) | |
Free Cash Flow |
(4.22) | (2.93) | (1.84) | (0.66) | |
Capital Expenditures |
(0.02) | (0.02) | (0.02) | (0.02) | |
Piotroski F-Score |
2.00 | 2.00 | 2.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
(88.86%) | (61.37%) | (42.37%) | (10.68%) | |
Accounts Receivable Turnover |
14.06 | 15.19 | 16.14 | 10.81 | |
Accounts Payable Turnover |
1.02 | 1.19 | 0.87 | 1.16 | |
Inventory Turnover |
0.64 | 0.68 | 0.67 | 0.80 | |
Average Days of Payables |
441.64 | 396.79 | 461.62 | 372.43 | |
Days of Inventory on Hand |
599.52 | 537.86 | 494.07 | 401.73 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
7.33% | 5.01% | 0.00% | 0.92% | |
Selling, General and Administrative Expense of Revenue |
138.35% | 129.00% | 120.09% | 112.59% | |
Share Based Compensation of Revenue |
17.77% | 18.74% | 15.38% | 17.08% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.63 | 0.51 | 0.40 | 0.16 | |
Depreciation/Fixed assets |
9.25 | 9.67 | 10.18 | 9.27 | |
Capex/Depreciation |
(0.09) | (0.08) | (0.08) | (0.08) | |
Revenue per Share |
0.11 | 0.11 | 0.10 | 0.10 | |
Operating CF per Share |
(0.05) | (0.04) | (0.02) | (0.01) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
(74.66%) | (63.77%) | (51.30%) | (43.98%) |
Columns are period end dates